Author | Andrew Kennedy, MD | OncLive

Author | Andrew Kennedy, MD

Articles

Dr. Kennedy on Next Steps With SIRFLOX Trial in Liver-Metastatic CRC

April 26, 2017

Video

Andrew Kennedy, MD, physician-in-chief and radiation oncologist at Sarah Cannon Research Institute, discusses the next steps following the SIRFLOX clinical trial for patients with liver-metastatic colorectal cancer (CRC).

Dr. Kennedy on Importance of SIRFLOX Study in Liver-Metastatic CRC

March 17, 2017

Video

Andrew Kennedy, MD, physician-in-chief and radiation oncologist at Sarah Cannon Research Institute, discusses the importance of the SIRFLOX trial, which explored the efficacy of selective internal radiation therapy (SIRT) with SIR-Spheres Y-90 resin microspheres as treatment for patients with liver-metastatic colorectal cancer (CRC) versus standard frontline chemotherapy.

Dr. Kennedy on the Utilization of Radioactive Microspheres

June 12, 2014

Video

Andrew Kennedy, MD, physician-in-chief, Radiation Oncology, Sarah Cannon, director, Radiation Oncology Research, Sarah Cannon Research Institute, discusses the utilization of radioactive microspheres.

x